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We genotyped SNP rs1229984 using a TaqMan Drug Metabolism Genotyping Assay 
in 569 stroke patients with extended clinical and lifestyle information and in 433 
controls with matching clinical and lifestyle information (Table 1). Case-control 
analysis was performed in SPSS (v20.0) and p-values and odds ratio were calculated 
using Pearson’s chi-squared test. The interpretation of the results allowed to 
determine the effect of the genetic variant on stroke susceptibility.  
All genotyping plates contained quality control samples: no-template controls, 
HapMap individuals and duplicated samples within and across genotyping plates. 
 
Table 1 – Characterization of the studied population 
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INTRODUCTION 
RESULTS 
Characteristic Controls Patients P 
Age and Gender 
Age, mean±SD (years) 64.0±5.5 51.6±8.9 <10-4* 
Gender (male), n/N (%) 201/433 (46.4) 362/569 (63.6) <10-4* 
Stroke type 
Ischemic stroke, n/N (%) - 451/569 (79.3) - 
Hemorrhagic stroke, n/N (%) - 107/569 (18.8) - 
Unknown type of stroke, n/N (%) - 11/569 (1.9) - 
Stroke Risk Factors 
Hypertension (>85-140mmHg), n/N (%) 157/426 (36.9) 313/500 (62.6) <10-4† 
Diabetes, n/N (%) 52/412 (12.6) 85/526 (16.2) 0.128† 
Hypercholesterolemia, n/N (%) (cholesterol > 200mg/dl) 296/433 (68.3) 329/519 (63.4) 0.108† 
Smoking, n/N (%) 120/423 (28.4) 257/557 (46.1) <10-4† 
  Drinking, n/N (%)~     <10-4† 
  None 254/407 (62.4) 242/558 (43.4)   
  Moderate consumption of alcohol 82/407 (20.1) 49/558 (8.8)   
  Excessive consumption of alcohol 71/407 (17.4) 267/558 (47.8)   
SD – standard deviation; ~Alcohol consumption was divided in three categories, according to the amount of alcohol consumed/day. 
None: <1 beverage/day; Moderate consumption: 1 beverage/day for females and 1-2 beverages/day for males; Excessive consumption: 
>1 beverage/day for females and >2 beverages/day for males (Rimm & Moats, 2007); * Mann-Whitney test; † Pearson’s Chi-squared test. 
METHODS 
Table 2 – Genotyping results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 – Association analysis results 
While heavy episodic drinking has been shown to be harmful to the heart, moderate 
alcohol consumption is thought to be protective against cardiovascular disease, 
through the regulation of rising HDL cholesterol levels.1 The cardio-protective effect 
of alcohol is now not thought to vary by beverage type. In fact, evidence for an 
additional cardio-protective effect of antioxidant polyphenols in red wine is weak.2-3 
The study of genetics variants of the alcohol dehydrogenase (ADH) and aldehyde 
dehydrogenase (ALDH) genes involved in alcohol metabolism is important to 
understand the patterns of drinking habits and its effects in stroke susceptibility. 
The enzyme alcohol dehydrogenase (ADH), which oxidizes alcohol to acetaldehyde, 
has proven to play an important role in alcohol metabolism. Seven genes encoding 
ADH are found in a tight cluster on chromosome 4 and some are polymorphic in 
white European populations.4 More active variants of ADH cause higher 
concentrations of acetaldehyde in the body following alcohol consumption and are 
therefore protective against drinking. Functional variants in both ADH1B and ADH1C 
have been associated with alcohol consumption or alcohol dependence.5-9 The 
ADH1B variant (rs1229984) has emerged as the most strongly associated with 
alcohol phenotypes and is therefore the most suitable instrument for Mendelian 
randomization studies in Europeans.6 The A allele has an allele frequency of 
approximately 2-5% in Europeans and plays a protective role against heavy drinking 
because it confers an higher alcohol metabolic rate and consequent accumulation of 
toxic acetaldehyde.10-11  
 
Hence  we analyzed if a possible association of the SNP rs1229984 with stroke 
susceptibility is mediated by the patterns of alcohol consumption. 
The SNP met quality control criteria and was 
further evaluated. 
Genotyping results are shown in Table 2. AA and AG 
genotypes were taken together for further analysis 
to enable a better statistical analysis. Association 
analysis between each two variables was 
performed and its results are shown in Table 3. 
  Stroke Alcohol comsumption 
Genotype 0.008 0.074 
Stroke -  <10-4 
On the associations analysis with significant results (genotype-stroke and alcohol consumption-stroke) we tested 
whether the third variable (alcohol consumption and genotype, respectively) was modifying the observed effect. As 
Tables 4 and 5 illustrate alcohol consumption modifies the association genotype-stroke (P=0.008) with excessive 
alcohol consumption playing the largest effect on this modification (P=0.034). Genotype also modifies the association 
alcohol consumption-stroke (P<10-4). 
Table 4 – Modifying effect of alcohol consumption on the association 
genotype-stroke 
Table 5 – Modifying effect of genotype on the association alcohol 
consumption-stroke  
Genotype Alcohol Consumption 
Stroke 
Total P OR 
Patients Controls 
AA and AG 
None 
N 34 40 74 
0.005 
0.85 
% 52.3% 55.6% 54.0% 
Moderate consumption 
N 6 19 25 
0.32 
% 9.2% 26.4% 18.2% 
Excessive consumption 
N 25 13 38 
1.92 
% 38.5% 18.1% 27.7% 
Total 
N 65 72 137 
  
% 100.0% 100.0% 100.0% 
GG 
None 
N 208 214 422 
<10-4 
1 
% 42.2% 63.9% 51.0% 
Moderate consumption 
N 43 63 106 
0.68 
% 8.7% 18.8% 12.8% 
Excessive consumption 
N 242 58 300 
4.17 
% 49.1% 17.3% 36.2% 
Total 
N 493 335 828 
  
% 100.0% 100.0% 100.0% 
Total 
None 
N 242 254 496 
<10-4 
  
% 43.4% 62.4% 51.4% 
Moderate consumption 
N 49 82 131 
  
% 8.8% 20.1% 13.6% 
Excessive consumption 
N 267 71 338 
  
% 47.8% 17.4% 35.0% 
Total 
N 558 407 965 
  
% 100.0% 100.0% 100.0% 
Alcohol Consumption Genotype 
Stroke 
Total P OR 
Patients Controls 
None 
AA and AG 
N 34 40 74 
0.596 
0.85 
% 14.0% 15.7% 14.9% 
GG 
N 208 214 422 
1 
% 86.0% 84.3% 85.1% 
Total 
N 242 254 496 
  
% 100.0% 100.0% 100.0% 
Moderate Consumption 
AA and AG 
N 6 19 25 
0.124 
0.46 
% 12.2% 23.2% 19.1% 
GG 
N 43 63 106 
0.68 
% 87.8% 76.8% 80.9% 
Total 
N 49 82 131 
  
% 100.0% 100.0% 100.0% 
Excessive Consumption 
AA and AG 
N 25 13 38 
0.034 
0.46 
% 9.4% 18.3% 11.2% 
GG 
N 242 58 300 
4.17 
% 90.6% 81.7% 88.8% 
Total 
N 267 71 338 
  
% 100.0% 100.0% 100.0% 
Total 
AA and AG 
N 65 72 137 
0.008 
  
% 11.6% 17.7% 14.2% 
GG 
N 493 335 828 
  
% 88.4% 82.3% 85.8% 
Total 
N 558 407 965 
  
% 100.0% 100.0% 100.0% 
Stroke Alcohol Consumption 
Genotype 
Total 
GG AG AA 
Patients 
None 208 32 2 242 
Moderate consumption 43 6 0 49 
Excessive consumption 242 23 2 267 
Total 493 61 4 558 
Controls 
None 214 37 3 254 
Moderate consumption 63 17 2 82 
Excessive consumption 58 12 1 71 
Total 335 66 6 407 
Total 
None 422 69 5 496 
Moderate consumption 106 23 2 131 
Excessive consumption 300 35 3 338 
Total 828 127 10 965 
DISCUSSION AND CONCLUSIONS 
(1) In this study we did not find an association between the SNP rs1229984 and alcohol phenotype. However, further studies in larger populations are needed to confirm these 
results. Also it would be interesting to observe whether the activity of ADH1B varies within groups of individuals sharing the same genotype, which might influence individual 
alcohol tolerance.  
(2) We tested whether the amount of alcohol consumed was modifying the association genotype-stroke and we observed, as expected12, that heavy drinking increases in about 
four times (OR=4.17) stroke risk in the group of A allele non-carriers. On the other hand, A carriers present a decrease to about half (OR=0.46) stroke risk despite the 
excessive alcohol consumption, which suggests that the A allele plays a protective role on stroke susceptibility. Further studies are needed to validate the same trend in 
groups of individuals with lighter alcohol consumption. 
(3) We confirmed the importance of alcohol as a stroke risk factor. While moderate consumption appears to be protective (OR<1), heavy drinking is potentially harmful (OR>1), 
as previously mentioned.1 However, when testing whether the genotype was modifying the association alcohol consumption-stroke, we observed a protective role of A allele, 
which is consistent with previous results. In fact, considering individuals with none or moderate alcohol consumption, A carriers show a decreased stroke risk when 
compared with non-carriers (0.85>ORA carriers>0.32 vs 1>ORA non carriers>0.68). Individuals consuming excessive amounts of alcohol, despite an increased stroke risk, have larger 
probability of developing an event if they are A non carriers (ORA carriers=1.92 vs ORA non carriers=4.17). 
 
In conclusion, A allele of the SNP rs1229984 appears to be protective against stroke. However, further studies are needed to replicate these results in other populations. Because 
the associations analyzed are complex, functional studies including other relevant genetic variants, such as ALDH, should be performed. Physiological studies including variables 
such as hypertension and hypercholesterolemia would also be interesting. 
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